Onchocerciasis

Case-control study Mahenge, Tanzania.

Year Started: 2021

HLA typing among cases and controls of onchocerciasis-associated epilepsy cases.



Access:
Open to applicants
Type:
Case-control
Status:
Completed
Consent restrictions:
No restrictions


Associated Data Type Procurement Timeframe
Biomarker datasets 0 - 3 months
Clinical records 0 - 3 months
Genomic datasets 0 - 3 months
Survey data 0 - 3 months
Participant Ethnicity 0 - 3 months
Microbiological results 0 - 3 months


Both sexes

Child (6 - 12 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Microscopic Assessment % of Sample Set
Serum -85°C to -60°C Not applicable 75% -99%
Dried whole blood -85°C to -60°C Not applicable 75% -99%


Both sexes

Adolescent (12 - 18 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Microscopic Assessment % of Sample Set
Serum -85°C to -60°C Not applicable 75% -99%
Dried whole blood -85°C to -60°C Not applicable 75% -99%

Onchocerciasis

Ov16 seroprevalence study among children 3-9 years old in Maridi South Sudan

Year Started: 2022

Ov16 seroprevalence study among children 3-9 years old in Maridi South Sudan



Access:
Open only through collaboration
Type:
Cross-sectional
Status:
Completed
Consent restrictions:
Genetic analysis restriction


Associated Data Type Procurement Timeframe
Biomarker datasets 0 - 3 months
Clinical records 0 - 3 months
Freezer temperature logs 0 - 3 months
Quality indicators 0 - 3 months
Microbiological results Immediate


Both sexes

Young child (2 - 6 years)

101 - 500 donors

Material Type Extraction Procedure Storage Temperature Preservation Type Microscopic Assessment % of Sample Set
Dried whole blood -35°C to -18°C Not applicable 100%